Actionable news
All posts from Actionable news

Second Sight Poaches Boston Scientific Executive To Manage Exceptional Manufacturing Growth

Second Sight recently hired two executives with experience in the manufacturing and commercialization of medical devices, including one from Boston Scientific.

My previous two articles provide an estimated range for EYES' Q1 numbers. Q1 results are out May 13, so it won't take long to see how accurate I am.

EYES' IPO lock-up expires in mid-May, but the company has incentives and catalysts in place to prevent any possible sell-off normally associated with IPO lock-ups.

Second Sight Medical Products, Inc. (NASDAQ:EYES) took another step towards becoming the leading provider of medical devices for the blind last Friday. The company announced two new additions to its executive team responsible for handling increased commercialization and manufacturing for its Argus II System. Tony Moses has been appointed to Commercial Vice President, Americas, and Jim Miller has been named the Director of Manufacturing. Mr. Moses has over 30 years of experience in the ophthalmic industry. Mr. Miller has spent over a decade working for Boston Scientific (NYSE:BSX) with his latest role being its Value Stream Production Manager. These two additions to Second Sight show that the company is preparing for a heavy period of growth in the near future.

In my first article on EYES I attached a $30 target to the company and made quarterly predictions for revenue, gross margin and operating loss. My second article presented updated Q1...